COPD and smoking

COPD and smoking

The effect of low-dose corticosteroids and theophylline on the risk of acute exacerbations of COPD: the TASCS randomised controlled trial
Christine R. Jenkins, Fu-Qiang Wen, Allison Martin, Peter J. Barnes, Bartolome Celli, Nan-Shan Zhong, Jin-Ping Zheng, Anish Scaria, Gian-Luca Di Tanna, Thomas Bradbury, Norbert Berend

European Respiratory Journal Jun 2021, 57 (6) 2003338; DOI: 10.1183/13993003.03338-2020
Methylxanthines in COPD: yes to caffeine, no to theophylline
Ken M. Kunisaki, Don D. Sin

European Respiratory Journal Jun 2021, 57 (6) 2004564; DOI: 10.1183/13993003.04564-2020
High eosinophil counts predict decline in FEV₁: results from the CanCOLD study
Wan C. Tan, Jean Bourbeau, Gilbert Nadeau, Wendy Wang, Neil Barnes, Sarah H. Landis, Miranda Kirby, James C. Hogg, Don D. Sin

European Respiratory Journal May 2021, 57 (5) 2000838; DOI: 10.1183/13993003.00838-2020
Real world effects of COPD medications: a cohort study with validation against results from randomised controlled trials
Kevin Wing, Elizabeth Williamson, James R. Carpenter, Lesley Wise, Sebastian Schneeweiss, Liam Smeeth, Jennifer K. Quint, Ian Douglas

European Respiratory Journal Mar 2021, 57 (3) 2001586; DOI: 10.1183/13993003.01586-2020
Markers of disease activity in COPD: an 8-year mortality study in the ECLIPSE cohort
Bartolome Celli, Nicholas Locantore, Julie C. Yates, Per Bakke, Peter M.A. Calverley, Courtney Crim, Harvey O. Coxson, David A. Lomas, William MacNee, Bruce E. Miller, Hana Mullerova, Stephen I. Rennard, Edwin K. Silverman, Emiel Wouters, Ruth Tal-Singer, Alvar Agusti, Jørgen Vestbo

European Respiratory Journal Mar 2021, 57 (3) 2001339; DOI: 10.1183/13993003.01339-2020
Life-course socioeconomic disadvantage and lung function: a multicohort study of 70 496 individuals
Vânia Rocha, Sílvia Fraga, Carla Moreira, Cristian Carmeli, Alexandra Lenoir, Andrew Steptoe, Graham Giles, Marcel Goldberg, Marie Zins, Mika Kivimäki, Paolo Vineis, Peter Vollenweider, Henrique Barros, Silvia Stringhini

European Respiratory Journal Mar 2021, 57 (3) 2001600; DOI: 10.1183/13993003.01600-2020
Mechanisms of orthopnoea in patients with advanced COPD
Amany F. Elbehairy, Azmy Faisal, Hannah McIsaac, Nicolle J. Domnik, Kathryn M. Milne, Matthew D. James, J. Alberto Neder, Denis E. O'Donnell

European Respiratory Journal Mar 2021, 57 (3) 2000754; DOI: 10.1183/13993003.00754-2020
A high-risk airway mycobiome is associated with frequent exacerbation and mortality in COPD
Pei Yee Tiew, Alison J. Dicker, Holly R. Keir, Mau Ern Poh, Sze Lei Pang, Micheál Mac Aogáin, Branden Qi Yu Chua, Jiunn Liang Tan, Huiying Xu, Mariko Siyue Koh, Augustine Tee, John Arputhan Abisheganaden, Fook Tim Chew, Bruce E. Miller, Ruth Tal-Singer, James D. Chalmers, Sanjay H. Chotirmall

European Respiratory Journal Mar 2021, 57 (3) 2002050; DOI: 10.1183/13993003.02050-2020
Accelerated FEV₁ decline and risk of cardiovascular disease and mortality in a primary care population of COPD patients
Hannah R. Whittaker, Chloe Bloom, Ann Morgan, Deborah Jarvis, Steven J. Kiddle, Jennifer K. Quint

European Respiratory Journal Mar 2021, 57 (3) 2000918; DOI: 10.1183/13993003.00918-2020
Assessment of chronic bronchitis and risk factors in young adults: results from BAMSE
Gang Wang, Jenny Hallberg, Petra Um Bergström, Christer Janson, Göran Pershagen, Olena Gruzieva, Marianne van Hage, Antonios Georgelis, Anna Bergström, Inger Kull, Anders Lindén, Erik Melén

European Respiratory Journal Mar 2021, 57 (3) 2002120; DOI: 10.1183/13993003.02120-2020

Main menu

User menu

Search

COPD and smoking

Pages

Contact us